Page last updated: 2024-12-11

morphine 6-nicotinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

morphine 6-nicotinate: RN given refers to (5alpha,6alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5488579
MeSH IDM0100275

Synonyms (16)

Synonym
morphine 6-nicotinate
unii-819768139g
75533-60-7
6-nicotinoylmorphine
morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-(5alpha,6alpha)-, 6-(3-pyridinecarboxylate)
819768139g ,
6-mononicotioylmorphine
morphin-6-nicotinat
J457.075H ,
6-mononicotinoylmorphine
morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5.alpha.,6.alpha.)-, 6-(3-pyridinecarboxylate)
morphine, 6-nicotinate
DTXSID00996994
3-hydroxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-yl pyridine-3-carboxylate
Q27269232
[(4r,4ar,7s,7ar,12bs)-9-hydroxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] pyridine-3-carboxylate

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The rate of absorption differs between patients and governs the overall pharmacokinetic profile of the compound."( Pharmacokinetics of intramuscular nicomorphine and its metabolites in man.
Booij, LH; Dirksen, R; Koopman-Kimenai, PM; Nijhuis, GM; Vree, TB, 1991
)
0.28

Bioavailability

ExcerptReferenceRelevance
" The rate of absorption differs between patients and governs the overall pharmacokinetic profile of the compound."( Pharmacokinetics of intramuscular nicomorphine and its metabolites in man.
Booij, LH; Dirksen, R; Koopman-Kimenai, PM; Nijhuis, GM; Vree, TB, 1991
)
0.28
"29), suggesting it is directly related to the absorption rate of nicomorphine."( The bioavailability of intramuscularly administered nicomorphine (Vilan) with its metabolites and their glucuronide conjugates in surgical patients.
Booij, LH; Dirksen, R; Koopman-Kimenai, PM; Vree, TB, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (28.57%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]